Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus

被引:100
作者
Mazarati, A
Lu, XY
Kilk, K
Langel, Ü
Wasterlain, C
Bartfai, T
机构
[1] W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA
[2] Univ Calif Los Angeles, D Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA
[3] Scripps Res Inst, Dept Neuropharmacol, Harold L Dorris Neurol Res Ctr, La Jolla, CA 92037 USA
[4] Stockholm Univ, Dept Neurochem & Neurotoxicol, SE-10691 Stockholm, Sweden
关键词
hippocampus; peptide nucleic acid antisense; plasticity; rat; status epilepticus;
D O I
10.1111/j.0953-816X.2004.03449.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The neuropeptide galanin has been implicated in inhibiting seizures and protecting hippocampal neurons from excitotoxic injury. In the hippocampus galanin acts through two receptor subtypes, GalR1, expressed in CA1, and GalR2, abundant in dentate gyrus. We developed an approach to induce and to study selective semichronic knockdown of GalR2 in the rat hippocampus. A 50% reduction of GalR2 binding was achieved by continuous infusion of complementary peptide nucleic acid antisense oligonucleotide into the dentate gyrus. This resulted in an increase in the severity of self-sustaining status epilepticus induced by electrical stimulation of the perforant path, induced mild neuronal injury in the dentate hilus, augmented seizure-induced hilar injury and inhibited seizure-induced neurogenesis in the subgranular zone of the dentate gyrus. Our data suggest that in the dentate gyrus, galanin, acting through GalR2, inhibits seizures, promotes viability of hilar interneurons and stimulates seizure-induced neurogenesis. These results are important for understanding the role of galanin and galanin receptor subtypes in the hippocampus both under normal conditions and in excitotoxic injury.
引用
收藏
页码:3235 / 3244
页数:10
相关论文
共 53 条
[1]  
ALTAR CA, 1990, EXP NEUROL, V109, P333
[2]   RNA interference: from an ancient mechanism to a state of the art therapeutic application? [J].
Arenz, C ;
Schepers, U .
NATURWISSENSCHAFTEN, 2003, 90 (08) :345-359
[3]   Galanin receptor subtypes [J].
Branchek, TA ;
Smith, KE ;
Gerald, C ;
Walker, MW .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (03) :109-116
[4]   Self-sustaining status epilepticus after a brief electrical stimulation of the perforant path: a 2-deoxyglucose study [J].
de Vasconcelos, AP ;
Mazarati, AM ;
Wasterlain, CG ;
Nehlig, A .
BRAIN RESEARCH, 1999, 838 (1-2) :110-118
[5]   Distribution and characterization of the cell types expressing GALR2 mRNA in brain and pituitary gland [J].
Depczynski, B ;
Nichol, K ;
Fathi, Z ;
Iismaa, T ;
Shine, J ;
Cunningham, A .
GALANIN: BASIC RESEARCH DISCOVERIES AND THERAPEUTIC IMPLICATIONS, 1998, 863 :120-128
[6]   Altered hippocampal expression of neuropeptides in seizure-prone GALR1 knockout mice [J].
Fetissov, SO ;
Jacoby, AS ;
Brumovsky, PR ;
Shine, T ;
Iismaa, TP ;
Hökfelt, T .
EPILEPSIA, 2003, 44 (08) :1022-1033
[7]   Neurogenesis in the adult brain [J].
Gage, FH .
JOURNAL OF NEUROSCIENCE, 2002, 22 (03) :612-613
[8]   Lesion-induced proliferation of neuronal progenitors in the dentate gyrus of the adult [J].
Gould, E ;
Tanapat, P .
NEUROSCIENCE, 1997, 80 (02) :427-436
[9]   Distribution of a rat galanin receptor mRNA in rat brain [J].
Gustafson, EL ;
Smith, KE ;
Durkin, MM ;
Gerald, C ;
Branchek, TA .
NEUROREPORT, 1996, 7 (04) :953-957
[10]   Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion [J].
Haberman, RP ;
Samulski, RJ ;
McCown, TJ .
NATURE MEDICINE, 2003, 9 (08) :1076-1080